Cochrane systematic review and meta-analysis of botulinum toxin for the prevention of migraine (2019)

First Author: Herd C

Attributed to: MICA: Assessing the therapeutic efficacy of 11beta-hydroxysteroid dehydrogenase type 1 inhibitor (AZD4017) in idiopathic intracranial hypertension funded by MRC

No abstract provided

Type: Journal Article/Review

Parent Publication: BMJ Open

Issue: 7